The family of a 22-year-old man who died after he couldn't afford his asthma medication testified before Wisconsin lawmakers ...

Adults with severe asthma who had poor inhaled corticosteroid/long-acting beta agonist adherence in their first year of tezepelumab did not differ from those with better adherence in several clinical ...

A new study has confirmed that male and female lungs are "wired differently" at the molecular level, providing further ...

The clinical-stage biotechnology company said the Phase 2 Valiant clinical trial, evaluating verekitug in adults with severe asthma, showed that verekitug reduced asthma attacks and improved lung ...

Evans was diagnosed with cystic fibrosis when she was 6 years old, leading to daily breathing treatments to manage the condition.

A federal lawsuit says an 18-month-old baby became critically ill in a South Texas immigration detention center, was ...

Researchers and doctors are beginning to modernize asthma treatment using innovative therapies. Asthma is a common, chronic, ...

Statin use had a statistically significant protective effect against acute asthma exacerbations in mild asthma among Black ...

A lingering cough is often blamed on asthma or past tuberculosis, but experts warn that a lesser-known fungal lung disease ...

Adults with mild-to-moderate asthma who take regular inhaled corticosteroids can achieve greater control of airway inflammation by also using the 2-in-1 combination budesonide-formoterol as a reliever ...

Upstream Bio, Inc. downgraded despite strong Verekitug phase 2 asthma results; assess anti-TSLP competition, dosing edge & catalysts. Click for this UPB update.